The Predictive Analytics for Cancer Diagnostic Market was valued at USD 16 billion in 2023 and is projected to reach a market size of USD 80.67 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 26%.
Petabytes and terabytes of data are being generated daily in the healthcare industry. We refer to this enormous volume of data as "Big Data." Pathologists, medical professionals, and other experts examine data to extract valuable information that aids in the accurate diagnosis of a disease. "Big Data Analytics" refers to this type of analysis done on a massive scale. Analysis might be prescriptive, diagnostic, descriptive, or predictive. Predictive analytics in healthcare is a difficult endeavor that requires machine learning. However, it also helps doctors treat patients accurately, saving them money, time, and most crucially, lives. Machine Learning (ML) facilitates effective decision-making and aids in the quick and accurate diagnosis of illness. AI in Cancer Diagnostics refers to the use of artificial intelligence technology, such as machine learning, predictive analysis, etc., across the entire process of treating cancer in a human body, from diagnosis to post-treatment surveillance.
Key Market Insights
Medical scientists' attention has been drawn back to the use of predictive analytics in early cancer screening and diagnosis as a result of the concerning and steadily increasing numbers. because early cancer detection and treatment can lower cancer mortality and morbidity.
The International Agency for Research on Cancer (IARC) has released data on worldwide cancer epidemiology through Globocon 2020, one of its major cancer surveillance programs. 19,292,789 new cases of cancer were recorded in 2020, which is two times more than the number of cases reported in 2018. 9,958,133 cancer-related fatalities were reported in the same year as the over 19 million instances of cancer that were documented. According to the International Agency for Research on Cancer (IARC) projections, one in five people will get cancer throughout their lifetime.
As to the research report titled "Global Artificial Intelligence (AI) in Cancer Diagnostic Market Analysis, 2021," the automated functionalities of AI hold the potential to improve the quality of diagnosis and therapy. Because of this, there is a growing need to include AI in cancer diagnostics, which will drive the market's expansion as a whole in the upcoming years.
Predictive Analytics for Cancer Diagnostic Market Drivers:
The application of predictive analytics to medical decision-making has shown to be highly beneficial. Every kind of treatment has a particular effect on a patient, especially for chronic conditions.
Determining who is in danger, gives medical practitioners the chance to prevent chronic diseases and intervene early. Providers can use predictive analytics to identify patients who may be at high risk for developing certain chronic illnesses, including diabetes, obesity, renal disease, cancer, and cardiovascular disease. Researchers at the University of Michigan Rogel Cancer Centre are developing a blood test that, in comparison to standard imaging scans, can indicate, months in advance, whether a certain treatment approach for HPV-positive throat cancer is effective. Numerous subtypes of cancer have been identified, making it a diverse disorder. Since early detection of cancer aids in patient therapy, prompt cancer screening and treatment are essential prerequisites for early cancer research. Numerous scientific groups investigated the use of machine learning (ML) and deep learning techniques in biomedicine and bioinformatics to categorize cancer patients into high- or low-risk groups. As a result, the genesis and therapy of cancer have been modeled after these strategies.
The growing number of cancer patients is the main driver propelling the market for predictive analytics for cancer diagnostics.
One practical medical issue is determining the appropriate classification scheme for cancer. One of the main causes of death in the world today is cancer. As a result, the scientific community now views research into cancer diagnosis as crucial. Early detection of cancer is the main challenge in its therapy. Frequently, cancer is discovered in its advanced stages, when it has spread throughout the body and interfered with the ability of essential organ systems to operate. Therefore, it's critical to diagnose cancer early. AI algorithms offer quantitative measures for improved analysis and improve diagnostic accuracy.
The market is expanding as a result of rising consumer awareness of the value of early cancer detection.
People are going for routine diagnostic exams and screenings to keep an eye on their health. A lot of public education programs regarding the advantages of early intervention are also being organized by healthcare organizations and providers, encouraging proactive health-seeking behavior. Beyond this, early detection lowers the entire healthcare burden related to advanced-stage cancer while also improving treatment outcomes. Around the world, governments and medical facilities are highlighting the value of early cancer diagnosis and offering easily accessible screening programs. By encouraging people to get regular cancer screenings, these programmers are having a positive impact on the market.
Predictive Analytics for Cancer Diagnostic Restraints and Challenges:
Lack of Understanding of AI's Use in the Healthcare Sector Could Limit Market Growth
AI in cancer diagnostics requires working with huge datasets and having an understanding of the possible benefits and limitations of deep learning technologies. Therefore, the largest obstacle that can prevent the market from growing in the upcoming years is a lack of information and training regarding AI systems. Furthermore, because AI may be used to obtain sensitive personal data like genetic sequences, privacy may potentially be violated, which could further impede market expansion.
The adoption of the technology is currently one of artificial intelligence's largest obstacles.
Today, one of the largest obstacles facing artificial intelligence is getting the technology accepted in the real world. The deployment of analytical instruments and infrastructure for laboratory analysis of cancer samples requires a major financial investment, expertise, and time commitment, which hinders the market's growth. This is especially noticeable when setting up pricey machines like next-generation sequencing platforms, PET, SPECT, and MRI scanners. Furthermore, despite the significant expenses connected with their creation and deployment, these goods are not economically viable. One of the main things holding back the market's expansion is this uncertainty. This is especially true when it comes to diagnosing terminally sick patients, when the patient's ability to make decisions may ultimately determine how long they live. This issue is exacerbated by the AI black box dilemma. Programmers can only observe input and output data; the inner workings of algorithms are unknown. This is referred to as AI black box.
Predictive Analytics for Cancer Diagnostic Market Opportunities:
One of the biggest problems in the detection and treatment of cancer has been addressed by the application of predictive analytics. It can aid in the early detection of precancerous lesions and lower the cancer patient death rate. By accurately detecting and predicting cancer, AI/ML helps to lower the rate of overdiagnosis, false positives, and false negatives. When using radiotherapy and immunotherapy, these methods can also be utilized to monitor the malignancies' prognosis. By creating tailored treatments for individual tumors, AI and ML may potentially be used to create personalized medications.
The prognosis for cancer treatment would be significantly enhanced by early and accurate cancer detection. Early cancer detection will have a significant financial influence on expensive cancer therapies. Since early cancer discovery may significantly reduce mortality rates, this could potentially have a significant effect on cancer survival rates.
Predictive analytics provides a better way to find a solution, and when the term "Data Science is everywhere" gained traction, biomedical researchers began exploring AI and ML. Renowned artificial intelligence (AI) professor Regina Barzilay, who also survived breast cancer, shared an inspirational story about how her diagnosis changed her research focus. She proposed that greater clinical data may be extracted by AI and ML systems, enabling doctors to make informed judgments. To assist physicians in interpreting radiological diagnostic images, she gathered information from medical reports and created machine-learning algorithms.
PREDICTIVE ANALYTICS FOR CANCER DIAGNOSTIC MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
26% |
|
Segments Covered |
By Tools, Applications, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientifica Inc, Qiagen bioMérieux |
Artificial intelligence
Machine learning
Predictive analytics can benefit greatly from artificial intelligence (AI), which is an area of computer science that deals with simulating intelligent behavior in computers. Put otherwise, it refers to a machine's ability to mimic intelligent human behavior 1950, Alan Turing, one of the forerunners in the field of artificial intelligence, wrote a paper titled "Computing Machinery and Intelligence." To ascertain whether a computer is capable of displaying the same degree of intellect as humans, it created the so-called Turing test. Machine Learning (ML) techniques are used by the majority of Artificial Intelligence (AI) applications to identify patterns in the datasets. Future results are predicted using these patterns.
The process by which a computer can constantly improve its performance by incorporating new data into an existing statistical model is known as machine learning (ML), and it is another tool for predictive analytics. It enables the system to update itself as new data is added, thereby improving the task's accuracy. The radiodiagnosis of precancerous lesions and tumors has long made use of the AI/ML idea as a predictive analytics tool. To help clinicians make informed judgments on the diagnosis and course of tumors, the AI system scans the images produced by several radiological procedures, such as MRIs and PET scans, and interprets the information contained in them. The AI system logs people's speech patterns, evaluates the information, and alerts the patient to potential early warning indicators of the illness. Although the app is unable to provide a formal diagnosis, users can bring the material to their physician for assessment.
With a revenue share of 40.68% in 2022, the biomarker development segment led the next-generation cancer diagnostic market based on application. This was because biomarker tests have shown high levels of accuracy, up to 90% in investigational studies, and they can improve sensitivity in tumor screening.
Breast cancer
Cervical cancer
Lung Cancer
Thyroid Cancer
Prostate Cancer
Breast cancer, prostate cancer, lung cancer, colorectal cancer, cervical cancer, and other cancers such as pancreatic, skin, blood, etc. are the market categories based on the kind of cancer. The market for breast cancer diagnostics was estimated to be worth USD 4.3 billion in 2022, and between 2023 and 2030, it is projected to expand at a compound annual growth rate (CAGR) of 7.4%. As one of the most common diseases in the world, breast cancer is expected to become more common, which will drive the market's expansion. The first AI-based predictive analytics system for breast cancer diagnosis has received approval from the FDA's Centre for Devices and Radiological Health (CDRH). Qlarity Imaging (Paragon Biosciences LLC) created QuantX. QuantX is a computer-aided diagnostic (CAD) software system that helps radiologists use magnetic resonance imaging (MRI) data to diagnose and characterize breast abnormalities.
With a revenue share of 44.28%, the other cancer category led the next-generation cancer diagnostic market in terms of cancer type in 2022. The domination of the market is a result of the growing developments in next-generation technologies, which have made it possible to identify and profile different kinds of biomarkers with more accuracy and comprehensiveness.
Therefore, it strongly suggests that artificial intelligence (AI) is needed for cancer diagnosis and breast cancer treatment. Furthermore, the World Health Organization states that early cancer diagnosis can significantly lower the possibility of death and raise the likelihood of a full recovery. This can be readily accomplished by incorporating AI technology into the screening and detection of breast cancer. The National Cancer Institute has also created a computer-aided program (CAD) that examines digital photos of a woman's cervix to spot alterations that may be precancerous and need to be checked out right away. Automated Visual Evaluation is the name of this Artificial Intelligence-based method (AVE).
North America
Asia-Pacific
Europe
South America
Middle East and Africa
North America's enhanced healthcare infrastructure allowed it to hold the largest market share. Aside from this, the increasing emphasis on early illness identification in people is fostering the expansion of the business in the area. Most of the newly established businesses in the same industry have a good foothold in the area. Prostate cancer imaging and analysis results have been proved by one of Microsoft system's Inner Eyes in a matter of minutes. Accordingly, the market is expanding as a result of rising cancer awareness and advantageous reimbursement practices. In addition, the North American market is expanding due to the presence of major producers of diagnostic technology, research institutes, and a robust network of healthcare facilities.
Several variables, including the expansion of healthcare reforms, are likely to contribute to the Asia Pacific market's expected profitable growth. The expansion of several well-known companies into the Asia Pacific region is anticipated to have a favorable effect on the market for cancer diagnostics. The governments of Singapore and Taiwan provide financial and regulatory support that is advantageous.
COVID-19 Impact Analysis on the Predictive Analytics for Cancer Diagnostic Market:
There was a 30% decline in nearly every economy in the world. As the healthcare industry shifted its focus to solving the current issue of the coronavirus epidemic, the use of AI in cancer diagnosis also saw a minor decline. Cancer patients' visits for treatment were impacted by the COVID-19 outbreak.
In addition, screening program suspensions, health system closures, delayed diagnosis, and restricted access to medical facilities were all consequences of the epidemic. Short-term decreases in cancer incidence, an increase in diagnoses for advanced stages of the disease, and a rise in cancer mortality were caused by these causes.
Latest Trends/ Developments:
Researchers at New York University supported by the NCI employed Deep Learning (DL) algorithms in conjunction with Predictive Analytics to detect gene alterations from pathophysiological pictures of lung tumors. An algorithm that can identify particular gene mutations based on visual examination of the pathophysiological images was developed using the pathophysiological images of lung cancers that were gathered from the Cancer Genome Atlas. Based on the image analysis, this method can predict the various types of lung tumors and the associated gene alterations with high accuracy.
Using Deep Convoluted Neural Network (DCNN) models, ultrasound image analysis was utilized to create an accurate diagnostic tool for thyroid malignancies.
Key Players:
There are many domestic and foreign competitors in the highly fragmented cancer diagnostics market. To increase their market position, major players are implementing a variety of growth tactics, including alliances, partnerships, joint ventures, new product launches, geographic expansions, mergers, and acquisitions.
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientifica Inc
Qiagen
bioMérieux
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Predictive Analytics for Cancer Diagnostic Market was valued at USD 16 billion in 2023.
Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 26 %.
The growing number of cancer patients, the benefits of predictive analytics, and consumer awareness about early screening are the main drivers.
The key players in the Pharmaceutical Amino Acid market are Abbott Laboratories Hoffmann-La Roche Ltd, Thermo Fisher Scientifica Inc, Qiagen, and bioMérieux.
Breast cancer is expected to become more common, which will drive the market's expansion.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
